Stockreport

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Genmab A/S - American Depositary Shares  (GMAB) 
PDF Company Announcement Johnson & Johnson has decided that it will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBod [Read more]